XML 48 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Business Combinations (Details)
CAD in Millions
9 Months Ended
Jan. 02, 2018
USD ($)
Apr. 03, 2017
USD ($)
Dec. 28, 2016
USD ($)
pharmacy
Dec. 28, 2016
CAD
Dec. 31, 2017
USD ($)
pharmacy
Dec. 31, 2017
CAD
pharmacy
Dec. 31, 2016
USD ($)
Mar. 31, 2018
USD ($)
Dec. 31, 2017
CAD
Mar. 31, 2017
USD ($)
Business Acquisition [Line Items]                    
Net purchase consideration         $ 1,979,000,000   $ 4,174,000,000      
Goodwill         11,828,000,000         $ 10,586,000,000
Gain (loss) on sale of stores         155,000,000   (113,000,000)      
CoverMyMeds, LLC (CMM)                    
Business Acquisition [Line Items]                    
Net purchase consideration   $ 1,300,000,000                
Assets acquired as of the acquisition date, excluding goodwill and intangibles   52,000,000                
Liabilities assumed as of the acquisition date   7,000,000                
Goodwill   870,000,000                
Acquired identifiable intangibles   $ 487,000,000                
intraFUSION, BDI Pharma, LLC, and Uniprix Group [Member]                    
Business Acquisition [Line Items]                    
Net purchase consideration         480,000,000          
Goodwill         235,000,000          
Acquired identifiable intangibles         $ 118,000,000          
Uniprix Group | CANADA                    
Business Acquisition [Line Items]                    
Number of Pharmacies Operated | pharmacy         375 375        
Rexall Health | CANADA                    
Business Acquisition [Line Items]                    
Net purchase consideration     $ 2,100,000,000 CAD 2,900            
Assets acquired as of the acquisition date, excluding goodwill and intangibles         $ 560,000,000          
Liabilities assumed as of the acquisition date         $ 210,000,000          
Goodwill     948,000,000              
Acquired identifiable intangibles     $ 872,000,000              
Number of retail pharmacies | pharmacy     450              
Number of retail pharmacies sold | pharmacy         27 27        
Gain (loss) on sale of stores         $ 0          
Vantage Oncology Holdings, LLC (“Vantage”), Biologics, Inc., UDG Healthcare Plc (“UDG”) and Other Businesses                    
Business Acquisition [Line Items]                    
Net purchase consideration             $ 2,000,000,000      
Additional amount, Up to | CoverMyMeds, LLC (CMM)                    
Business Acquisition [Line Items]                    
Contingent consideration               $ 160,000,000    
Customer relationships | CoverMyMeds, LLC (CMM)                    
Business Acquisition [Line Items]                    
Weighted average life of intangibles   17 years                
Customer relationships | Rexall Health | CANADA                    
Business Acquisition [Line Items]                    
Weighted average life of intangibles     19 years 19 years            
Trade Names | Rexall Health | CANADA                    
Business Acquisition [Line Items]                    
Weighted average life of intangibles     19 years 19 years            
Estimate of Fair Value | CoverMyMeds, LLC (CMM)                    
Business Acquisition [Line Items]                    
Contingent consideration   $ 113,000,000                
Third Party Buyer | Rexall Health | CANADA                    
Business Acquisition [Line Items]                    
Proceeds from sale of stores         94,000,000       CAD 116  
Third Party Seller of Rexall Health | Rexall Health | CANADA                    
Business Acquisition [Line Items]                    
Proceeds for settlement of post-closing purchase price adjustment         $ 119,000,000 CAD 147        
Subsequent Event | RxCrossroads                    
Business Acquisition [Line Items]                    
Net purchase consideration $ 724,000,000